AERSALE CORP (ASLE)

US00810F1066 - Common Stock

6.23  +0.07 (+1.14%)

After market: 6.23 0 (0%)

Fundamental Rating

3

Overall ASLE gets a fundamental rating of 3 out of 10. We evaluated ASLE against 65 industry peers in the Aerospace & Defense industry. The financial health of ASLE is average, but there are quite some concerns on its profitability. ASLE has a correct valuation and a medium growth rate.



2

1. Profitability

1.1 Basic Checks

In the past year ASLE was profitable.
In the past year ASLE has reported a negative cash flow from operations.
Of the past 5 years ASLE 4 years were profitable.
In the past 5 years ASLE reported 4 times negative operating cash flow.

1.2 Ratios

With a Return On Assets value of 0.07%, ASLE is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
ASLE has a Return On Equity (0.09%) which is in line with its industry peers.
The Return On Invested Capital of ASLE (0.51%) is worse than 65.63% of its industry peers.
Industry RankSector Rank
ROA 0.07%
ROE 0.09%
ROIC 0.51%
ROA(3y)4.89%
ROA(5y)3.48%
ROE(3y)5.81%
ROE(5y)4.08%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ASLE has a Profit Margin of 0.12%. This is in the lower half of the industry: ASLE underperforms 60.94% of its industry peers.
With a Operating Margin value of 1.09%, ASLE is not doing good in the industry: 65.63% of the companies in the same industry are doing better.
ASLE's Gross Margin of 28.60% is fine compared to the rest of the industry. ASLE outperforms 73.44% of its industry peers.
ASLE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.09%
PM (TTM) 0.12%
GM 28.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.01%
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ASLE is destroying value.
Compared to 1 year ago, ASLE has more shares outstanding
ASLE has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ASLE has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 2.82 indicates that ASLE is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.82, ASLE is in line with its industry, outperforming 48.44% of the companies in the same industry.
ASLE has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.17, ASLE is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 2.82
ROIC/WACC0.05
WACC9.61%

2.3 Liquidity

A Current Ratio of 7.21 indicates that ASLE has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 7.21, ASLE belongs to the top of the industry, outperforming 98.44% of the companies in the same industry.
A Quick Ratio of 1.61 indicates that ASLE should not have too much problems paying its short term obligations.
The Quick ratio of ASLE (1.61) is better than 68.75% of its industry peers.
Industry RankSector Rank
Current Ratio 7.21
Quick Ratio 1.61

4

3. Growth

3.1 Past

ASLE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -75.00%.
ASLE shows a small growth in Revenue. In the last year, the Revenue has grown by 2.85%.
Measured over the past years, ASLE shows a quite strong growth in Revenue. The Revenue has been growing by 16.99% on average per year.
EPS 1Y (TTM)-75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)2.85%
Revenue growth 3Y16.99%
Revenue growth 5YN/A
Sales Q2Q%-10.6%

3.2 Future

ASLE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 78.45% yearly.
The Revenue is expected to grow by 6.35% on average over the next years.
EPS Next Y191.43%
EPS Next 2Y158.9%
EPS Next 3Y78.45%
EPS Next 5YN/A
Revenue Next Year-15.88%
Revenue Next 2Y-0.03%
Revenue Next 3Y6.35%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 77.88, the valuation of ASLE can be described as expensive.
ASLE's Price/Earnings is on the same level as the industry average.
ASLE's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.41.
With a Price/Forward Earnings ratio of 13.28, ASLE is valued correctly.
Based on the Price/Forward Earnings ratio, ASLE is valued cheaper than 96.88% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ASLE to the average of the S&P500 Index (23.69), we can say ASLE is valued slightly cheaper.
Industry RankSector Rank
PE 77.88
Fwd PE 13.28

4.2 Price Multiples

ASLE's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 22.8

4.3 Compensation for Growth

ASLE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ASLE's earnings are expected to grow with 78.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.41
PEG (5Y)N/A
EPS Next 2Y158.9%
EPS Next 3Y78.45%

0

5. Dividend

5.1 Amount

ASLE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AERSALE CORP

NASDAQ:ASLE (1/3/2025, 8:20:43 PM)

After market: 6.23 0 (0%)

6.23

+0.07 (+1.14%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners55.15%
Inst Owner Change-8.91%
Ins Owners7.32%
Ins Owner Change1.96%
Market Cap331.50M
Analysts77.78
Price Target8.16 (30.98%)
Short Float %6.71%
Short Ratio5.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-87.74%
Min EPS beat(2)-149.02%
Max EPS beat(2)-26.47%
EPS beat(4)1
Avg EPS beat(4)-31.52%
Min EPS beat(4)-149.02%
Max EPS beat(4)153.75%
EPS beat(8)2
Avg EPS beat(8)-45.49%
EPS beat(12)5
Avg EPS beat(12)5.64%
EPS beat(16)9
Avg EPS beat(16)74.52%
Revenue beat(2)0
Avg Revenue beat(2)-12.96%
Min Revenue beat(2)-13.25%
Max Revenue beat(2)-12.68%
Revenue beat(4)1
Avg Revenue beat(4)-15.7%
Min Revenue beat(4)-40.8%
Max Revenue beat(4)3.91%
Revenue beat(8)1
Avg Revenue beat(8)-17.52%
Revenue beat(12)4
Avg Revenue beat(12)-7.79%
Revenue beat(16)6
Avg Revenue beat(16)15.43%
PT rev (1m)4.35%
PT rev (3m)-4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-40.1%
EPS NY rev (1m)-1.64%
EPS NY rev (3m)-21.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.86%
Revenue NY rev (1m)-2.19%
Revenue NY rev (3m)-5.99%
Valuation
Industry RankSector Rank
PE 77.88
Fwd PE 13.28
P/S 0.96
P/FCF N/A
P/OCF N/A
P/B 0.73
P/tB 0.81
EV/EBITDA 22.8
EPS(TTM)0.08
EY1.28%
EPS(NY)0.47
Fwd EY7.53%
FCF(TTM)-0.84
FCFYN/A
OCF(TTM)-0.61
OCFYN/A
SpS6.48
BVpS8.49
TBVpS7.72
PEG (NY)0.41
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.07%
ROE 0.09%
ROCE 0.68%
ROIC 0.51%
ROICexc 0.52%
ROICexgc 0.57%
OM 1.09%
PM (TTM) 0.12%
GM 28.6%
FCFM N/A
ROA(3y)4.89%
ROA(5y)3.48%
ROE(3y)5.81%
ROE(5y)4.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.01%
GM growth 5YN/A
F-Score2
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA 4.49
Cap/Depr 89.45%
Cap/Sales 3.59%
Interest Coverage 0.73
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.21
Quick Ratio 1.61
Altman-Z 2.82
F-Score2
WACC9.61%
ROIC/WACC0.05
Cap/Depr(3y)65.76%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y191.43%
EPS Next 2Y158.9%
EPS Next 3Y78.45%
EPS Next 5YN/A
Revenue 1Y (TTM)2.85%
Revenue growth 3Y16.99%
Revenue growth 5YN/A
Sales Q2Q%-10.6%
Revenue Next Year-15.88%
Revenue Next 2Y-0.03%
Revenue Next 3Y6.35%
Revenue Next 5YN/A
EBIT growth 1Y697.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year74.64%
EBIT Next 3Y53.87%
EBIT Next 5YN/A
FCF growth 1Y-204.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-164.49%
OCF growth 3YN/A
OCF growth 5YN/A